BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34276688)

  • 1. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
    Stephens AJ; Burgess-Brown NA; Jiang S
    Front Immunol; 2021; 12():696791. PubMed ID: 34276688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of tumour peptide vaccines: From universalization to personalization.
    Ma M; Liu J; Jin S; Wang L
    Scand J Immunol; 2020 Jun; 91(6):e12875. PubMed ID: 32090366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte elicited therapeutic vaccine candidate targeting cancer against MAGE-A11 carcinogenic protein.
    Kumar N; Sood D; Gupta A; Jha NK; Jain P; Chandra R
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
    Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
    Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation peptide vaccines for advanced cancer.
    Yamada A; Sasada T; Noguchi M; Itoh K
    Cancer Sci; 2013 Jan; 104(1):15-21. PubMed ID: 23107418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic cancer vaccines.
    Saxena M; van der Burg SH; Melief CJM; Bhardwaj N
    Nat Rev Cancer; 2021 Jun; 21(6):360-378. PubMed ID: 33907315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-based vaccines for cancer therapy.
    Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
    Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite peptide-based vaccines for cancer immunotherapy (Review).
    Yang J; Zhang Q; Li K; Yin H; Zheng JN
    Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epitope peptide vaccine with oncoantigen for cancer and its biomarker].
    Hazama S; Maeda K; Oka M
    Nihon Rinsho; 2012 Dec; 70(12):2189-93. PubMed ID: 23259395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized cancer vaccines: adjuvants are important, too.
    Gouttefangeas C; Rammensee HG
    Cancer Immunol Immunother; 2018 Dec; 67(12):1911-1918. PubMed ID: 29644387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide vaccines in early breast cancer.
    Criscitiello C; Viale G; Curigliano G
    Breast; 2019 Apr; 44():128-134. PubMed ID: 30769238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunotherapy of cancer in elderly patients.
    Matzku S; Zöller M
    Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Derived Antigenic Peptides as Potential Cancer Vaccines.
    Sotirov S; Dimitrov I
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in non-renal carcinomas.
    Keilholz U
    Urologe A; 2004 Sep; 43 Suppl 3():S138-40. PubMed ID: 15148577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor vaccination using peptide based vaccines.
    Eisenbach L; Bar-Haim E; El-Shami K
    Immunol Lett; 2000 Sep; 74(1):27-34. PubMed ID: 10996624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.
    Sayour EJ; Mitchell DA
    J Immunol Res; 2017; 2017():3145742. PubMed ID: 28265580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.